Prediction of mortality and organ failure based on coagulation and fibrinolysis markers in patients with acute pancreatitis

Abstract This study explored the predictive value of coagulation and fibrinolysis markers with acute pancreatitis (AP)-related mortality and organ failure. We retrospectively reviewed and analyzed coagulation and fibrinolysis markers and clinical outcomes of the patients with AP. A total of 273 patients with AP were enrolled, 7 patients died and 28 patients suffered from organ failure. Uni- and multivariate logistic regression identified the differences of all of the coagulation and fibrinolysis markers as risk factors for AP-related mortality. The differences of APTT value, TT value, D-dimmer level, FDP level, and AT III level were risk factors for organ failure. Furthermore, the OR of the differences of platelet, PT, APTT, TT, fibrinogen, D-dimmer, FDP, and AT III was substantially improved by grouping with intervals of 10 × 109/L, 2 seconds, 5 seconds, 3 seconds, 0.5 g/L, 3 mg/L FEU, 5 mg/L and 10%, respectively. The risk of mortality can increase up to 1.62, 5.17, and 5.60 fold for every 10 × 109/L, 2 seconds and 5 seconds of increase in platelet, PT and APTT, respectively. There is approximate 2-fold increase in risk of organ failure for every 2 seconds of TT increase. In receiver operating characteristic analysis, there is no difference in the predictive power of bedside index for severity in acute pancreatitis (BISAP) with them in mortality or organ failure. In patients with AP, the dynamic changes of coagulation and fibrinolysis markers are good predictors for AP-related mortality and organ failure, especially platelet, PT and APTT in mortality and TT in organ failure.

[1]  M. Freeman,et al.  Current Concepts in Severe Acute and Necrotizing Pancreatitis: An Evidence-Based Approach. , 2019, Gastroenterology.

[2]  E. Redondo-Cerezo,et al.  BISAP, RANSON, lactate and others biomarkers in prediction of severe acute pancreatitis in a European cohort , 2017, Journal of gastroenterology and hepatology.

[3]  A. Tran,et al.  Assessment of D-Dimers for the Early Prediction of Complications in Acute Pancreatitis , 2016, Pancreas.

[4]  S. Trocha,et al.  What is the Risk of Diagnostic Endoscopic Retrograde Cholangiopancreatography before Cholecystectomy? , 2014, The American surgeon.

[5]  C. Iancu,et al.  Risk factors for complications after duodenopancreatectomy. Initial results after implementing a standardized perioperative protocol. , 2014, Chirurgia.

[6]  N. Gubergrits,et al.  [Polymorphism of ethanol metabolism genes in alcoholic chronic pancreatitis]. , 2014, Terapevticheskii arkhiv.

[7]  L. Gordon,et al.  Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event. , 2013, Blood.

[8]  J. Niu,et al.  Interleukin-6, interleukin-8 and interleukin-10 in estimating the severity of acute pancreatitis: an updated meta-analysis. , 2014, Hepato-gastroenterology.

[9]  A. Sijacki,et al.  Interleukin-12 as a predictor of outcome in patients with severe acute pancreatitis. , 2014, Hepato-gastroenterology.

[10]  Ambady Ramachandran,et al.  Treatment with DPP-4 inhibitors does not increase the chance of pancreatitis in patients with type 2 diabetes. , 2013, The Journal of the Association of Physicians of India.

[11]  N. Pannu,et al.  Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  S. Köklü,et al.  Alterations of platelet function and coagulation parameters during acute pancreatitis , 2013, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[13]  Seth D. Crockett,et al.  Burden of gastrointestinal disease in the United States: 2012 update. , 2012, Gastroenterology.

[14]  Colin D Johnson,et al.  Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus , 2012, Gut.

[15]  Chuan-xin Wu,et al.  Utility of Clot Formation and Lysis Assay to Monitor Global Coagulation State of Patients with Severe Acute Pancreatitis , 2012, Digestive Diseases and Sciences.

[16]  H. Repo,et al.  Thrombin Generation in vitro and in vivo, and Disturbed Tissue Factor Regulation in Patients with Acute Pancreatitis , 2011, Pancreatology.

[17]  Heikki Repo,et al.  Inflammation and immunosuppression in severe acute pancreatitis. , 2010, World journal of gastroenterology.

[18]  D. Radenkovic,et al.  d-Dimer in Acute Pancreatitis: A New Approach for an Early Assessment of Organ Failure , 2009, Pancreas.

[19]  H. Repo,et al.  Hemostatic Gene Polymorphisms in Severe Acute Pancreatitis , 2009, Pancreas.

[20]  Bechien U. Wu,et al.  The early prediction of mortality in acute pancreatitis: a large population-based study , 2008, Gut.

[21]  M. Singer,et al.  The Pancreatitis Outcome Prediction (POP) Score: A new prognostic index for patients with severe acute pancreatitis* , 2007, Critical care medicine.

[22]  C. Christophi,et al.  Disturbances of the microcirculation in acute pancreatitis , 2006, The British journal of surgery.

[23]  H. Harris,et al.  Applying Ockham's Razor to Pancreatitis Prognostication: A Four-Variable Predictive Model , 2006, Annals of surgery.

[24]  T. van der Poll,et al.  Tissue factor in infection and severe inflammation. , 2006, Seminars in thrombosis and hemostasis.

[25]  M. Ohmuraya,et al.  Applicability of Disseminated Intravascular Coagulation Parameters in the Assessment of the Severity of Acute Pancreatitis , 2006, Pancreas.

[26]  Ireland,et al.  UK guidelines for the management of acute pancreatitis , 2005, Gut.

[27]  S. Sarna,et al.  Early prediction of organ failure by combined markers in patients with acute pancreatitis , 2005, The British journal of surgery.

[28]  C. Hack,et al.  Protective effect of antithrombin III in acute experimental pancreatitis in rats , 1992, Digestive Diseases and Sciences.

[29]  D. Radenkovic,et al.  Disorders of Hemostasis During the Surgical Management of Severe Necrotizing Pancreatitis , 2004, Pancreas.

[30]  W. Bechstein,et al.  [Acute pancreatitis]. , 2004, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

[31]  M. Lerch,et al.  Combined treatment with C1 esterase inhibitor and antithrombin III improves survival in severe acute experimental pancreatitis. , 1997, Gut.

[32]  C. Imrie,et al.  Prediction of outcome in acute pancreatitis: A comparative study of APACHE II, clinical assessment and multiple factor scoring systems , 1990, The British journal of surgery.

[33]  T. Amis,et al.  Respiratory failure , 2018, ERS Handbook Respiratory Medicine.